openPR Logo
Press release

Heart Valve Devices Market (2022-2032): Strategic Developments by Jena Valve Technology Inc , Cryolife, Inc, Liva Nova PLC, Boston Scientific Corporation, Micro Interventional Devices Inc

08-04-2025 10:53 AM CET | Health & Medicine

Press release from: Fact.MR Market Research

Heart Valve Devices Market

Heart Valve Devices Market

The global heart valve devices market is on a robust upward trajectory, anticipated to reach a valuation of US$ 37.5 Billion by the end of 2032. According to a recent market analysis by Fact.MR, the market was valued at US$ 11.16 Billion in FY 2022, rising from US$ 9.85 Billion in 2021 - a notable 13.3% year-on-year growth.

Over the next decade, the sector is projected to expand at an impressive CAGR of 13%, fueled by an aging global population, increasing prevalence of heart diseases, and growing adoption of minimally invasive surgical procedures.

The global rise in cardiovascular disorders, particularly valvular heart diseases (VHD), is a key driver of the heart valve devices market. As the geriatric population expands - particularly in North America, Europe, and Asia-Pacific - there is a heightened demand for advanced cardiac care solutions. Innovations in transcatheter valve replacement and repair systems are proving critical in addressing both structural heart conditions and improving patient outcomes.

Browse Full Report: https://www.factmr.com/report/4759/heart-valve-devices-market

Technological Advancements Reinventing Valve Replacement

The industry is experiencing a technological renaissance, with rapid advancements in transcatheter aortic valve replacement (TAVR), mitral valve repair systems, and hybrid valve platforms. These innovations are enabling quicker recovery times, reduced procedural risks, and lower hospital stays compared to conventional open-heart surgeries. The increased acceptance of less invasive procedures among both clinicians and patients is accelerating the adoption of new-generation heart valve devices.

Additionally, improved diagnostic imaging techniques, such as 3D echocardiography and cardiac CT, have enhanced procedural planning and real-time visualization, further boosting success rates and confidence in these medical interventions.

Competitive Landscape: Strategic Moves and Key Players

The heart valve devices market is characterized by strong competition, with several key players investing significantly in R&D, acquisitions, and partnerships to maintain market leadership and enter emerging markets. The following companies are at the forefront of shaping the industry:

Edwards Lifesciences Corporation - A market leader known for its SAPIEN series, the company continues to innovate in TAVR technology and expand its global footprint.

St. Jude Medical Inc. - Now a part of Abbott, the company remains a critical player with an extensive product pipeline in mitral and tricuspid valve technologies.

Boston Scientific Corporation - Diversifying its cardiovascular portfolio, Boston Scientific is focusing on structural heart therapies and leveraging strong R&D capabilities.

LivaNova PLC - With strengths in minimally invasive cardiac surgery, LivaNova is innovating on both mechanical and tissue heart valves.

CryoLife, Inc. - A pioneer in tissue-based solutions, CryoLife is developing next-gen bio-prosthetic valves.

Braile Biomedica and Medical Technology Est. - These companies are expanding in Latin America and the Middle East with cost-effective, high-performance heart valve products.

Micro Interventional Devices Inc. - Known for novel delivery systems that simplify valve implantations.

Jena Valve Technology Inc. - Specializing in transcatheter valve therapies for high-risk patients, especially with aortic regurgitation indications.

Recent Developments Driving Market Momentum

In recent months, market dynamics have been significantly influenced by several key developments. Edwards Lifesciences launched its next-generation TAVR platform with enhanced deployment precision, improving outcomes in intermediate-risk patients. Boston Scientific received FDA approval for a new mitral repair system designed for primary mitral regurgitation, a condition affecting millions globally.

Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=4759

Meanwhile, CryoLife announced expansion into Asia-Pacific through a joint venture, aiming to provide next-gen tissue valves to underserved markets. Jena Valve Technology secured additional Series C funding to advance its clinical trials and commercial readiness in Europe and the U.S.

These strategic investments and innovations highlight the industry's aggressive push toward addressing unmet clinical needs with safer, more efficient, and patient-friendly heart valve therapies.

Outlook and Growth Opportunities

As healthcare systems globally prioritize early diagnosis and intervention in cardiovascular conditions, heart valve device manufacturers are well-positioned to capitalize on these trends. The Asia-Pacific region, in particular, presents untapped opportunities due to rising healthcare infrastructure, growing awareness, and expanding medical tourism in countries like India, China, and Thailand.

The increasing use of artificial intelligence in cardiovascular imaging and robotics-assisted surgeries is also expected to redefine the heart valve treatment landscape, offering precision-guided procedures and enhanced patient personalization.

Conclusion

With heart diseases continuing to rank among the leading causes of death globally, the heart valve devices market is witnessing transformative growth. The convergence of aging demographics, innovation-driven strategies, and supportive regulatory frameworks is setting the stage for significant market expansion. For industry players, the coming decade offers vast potential to shape the future of cardiovascular healthcare with life-saving and quality-enhancing valve technologies.

Check out More Related Studies Published by Fact.MR Research:

Glenoid Fossa Prosthesis Market - https://www.factmr.com/report/1132/glenoid-fossa-prosthesis-market

Chloride Reagents Kits Market - https://www.factmr.com/report/1138/chloride-reagents-kits-market

Tracheobronchial Suction Catheters Market - https://www.factmr.com/report/1145/tracheobronchial-suction-catheters-market

Eye Sphere Implants Market - https://www.factmr.com/report/1156/eye-sphere-implants-market

Contact Us:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com

About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Valve Devices Market (2022-2032): Strategic Developments by Jena Valve Technology Inc , Cryolife, Inc, Liva Nova PLC, Boston Scientific Corporation, Micro Interventional Devices Inc here

News-ID: 4131199 • Views:

More Releases from Fact.MR Market Research

Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast Period
Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast …
Undecylenic acid, an unsaturated fatty acid derived from castor oil, is recognized for its antifungal properties. It is widely used in medical treatments for skin infections, as well as in the production of cosmetics and personal care products. The market is projected to witness higher single-digit growth globally during the forecast period, with regions like North America and Europe leading in volume, while the Middle East and Africa (MEA) are
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Functional Dairy Ingredients
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Func …
The global whey cheese market is witnessing remarkable growth, driven by increasing consumer preference for protein-rich, functional, and sustainable dairy products. According to recent research, the market is expected to reach USD 21.6 billion by 2035, up from USD 10.5 billion in 2024, marking a robust compound annual growth rate (CAGR) of 6.8% during the forecast period from 2025 to 2035. Rising Demand for Functional and Protein-Rich Foods Fuels Market Expansion The
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven by Innovation in Food and Beverage Applications
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven b …
The global enzyme-enhanced ingredients market is poised for remarkable growth, with the industry projected to reach USD 11,657 million by 2035, up from USD 5,955 million in 2024. This expansion is expected to occur at a robust compound annual growth rate (CAGR) of 6.5% between 2025 and 2035. The surge in demand is primarily driven by the rising adoption of enzyme-based solutions across food, beverage, and nutraceutical industries, alongside an
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding Applications in Pharmaceuticals, Food, and Cosmetics
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding App …
The global glycine market is poised for remarkable growth over the next decade, with market value projected to surge from USD 1,356.4 million in 2024 to USD 2,825.8 million by 2035. During the forecast period from 2025 to 2035, the industry is expected to expand at a robust CAGR of 6.9%, reflecting the increasing demand for this versatile amino acid across multiple end-use sectors. Glycine, the simplest amino acid, is

All 5 Releases


More Releases for Valve

Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure. According to Fact.MR’s
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market
Global Plug Valves Market: Yuandong Valve, Yuanda Valve, Weir, Walworth, Zhengqu …
Global Market Study Evaluate on Plug Valves Industry by Type, Manufacturers, Application, Type, and Regions, Forecast up to 2022 The scope of the global Plug Valves market report is: This report offers a comprehensive evaluation of the Plug Valves market. It does so by in-depth qualitative insights, historical Plug Valves market data, and verifiable projections about global Plug Valves market size. The projections featured in the Plug Valves market report have been